This work was supported by NIH/NIAID grants R01 AI-26815 and T32 AI-060555 (DI), and by NIH/ORIP selleck kinase inhibitor T32 OD-011147 (DI). References 1. Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med 1987, 107:725–731.PubMedCrossRef 2. Steere AC, Coburn J, Glickstein L: The emergence of Lyme disease. J Clin Invest 2004, 113:1093–1101.PubMed

3. Steere AC: Lyme disease. N Engl J Med 1989, 321:586–596.PubMedCrossRef 4. Barthold SW, de Souza MS, Janotka JL, Smith AL, Persing DH: Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993,143(3):951–971. 5. McKisic MD, Barthold SW: T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease. Infect Immun 2000, 68:5190–5197.PubMedCrossRef 6. Barthold SW, de Souza M, Feng S: Selonsertib Serum-mediated resolution of Lyme arthritis in mice. Lab Invest 1996, 74:57–67.PubMed 7. Barthold SW, Feng S, Bockenstedt LK, Fikrig Tucidinostat E, Feen K: Protective and arthritis- resolving activity in serum from mice infected with Borrelia burgdorferi . Clin Infect Dis 1997,

25:S9-S17.PubMedCrossRef 8. Barthold SW, Hodzic E, Tunev S, Feng S: Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect Immun 2006, 74:4817–4825.PubMedCrossRef 9. de Silva AM, Fikrig E: Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasit Today 1997, 13:267–270.CrossRef 10. de Silva AM, Fikrig E: Arthropod- and host-specific gene expression by Borrelia burgdorferi . J Clin Invest 1997, 99:377–379.PubMedCrossRef 11. Feng S, Hodzic E, Stevenson B, Barthold SW: Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun 1998, 66:2827–2835.PubMed 12. Feng S, Hodzic E, Barthold SW: Lyme arthritis resolution with antiserum to a 37- kilodalton Borrelia burgdorferi protein. Infect Immun 2000, 68:4169–4173.PubMedCrossRef 13. Fikrig E, Chen M, Barthold SW, Anguita J, Feng W, TelfordIII SR, Flavell RA: Borrelia burgdorferi erpT expression in the arthropod vector

and murine host. Mol Microbiol 1999, 31:281–290.PubMedCrossRef 14. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Hook M: Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects Cyclin-dependent kinase 3 against infection. Infect Immun 1998, 66:2143–2153.PubMed 15. Hagman KE, Yang X, Wikel SK, Schoeler GB, Caimano MJ, Radolph JD, Norgard MV: Decorin-binding protein A (DbpA) of Borrelia burgdorferi is not protective when immunized mice are challenged via tick infestation and correlates with the lack of DbpA expression by B. burgdorferi in ticks. Infect Immun 2000, 68:4759–4764.PubMedCrossRef 16. Feng S, Hodzic E, Freet K, Barthold SW: Immunogenicity of Borrelia burgdorferi arthritis-related protein. Infect Immun 2003, 71:7211–7214.PubMedCrossRef 17.